Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 218743

QID 218743 (Type "218743" in App Search)
A 14-year-old girl presents to her pediatrician for a routine wellness visit. During the interview, the patient discloses that she is concerned that she has not yet had her first period and that she isn’t “developing like the other girls at school.” She denies galactorrhea, recent changes in exercise habits, headaches, fatigue, or polyuria. She has no significant previous medical history and does not take any medications. Her height and weight are in the 40th and 50th percentile for her age respectively. Her mother had menarche at age 11. Her temperature is 98.6°F (37.0°C), blood pressure is 110/60 mmHg, pulse is 70/min, respirations are 16/min, and O2 saturation is 99% on room air. Physical examination is notable for Tanner stage 1 breasts and a lack of pubic hair. Serum studies show:

Thyroid-stimulating hormone (TSH): 3.5 mIU/L
Prolactin (PRL): 5 ng/mL
Beta human chorionic gonadotropin (beta-hCG): negative

Ultrasound shows that the uterus is present, and no other anatomic abnormalities are noted on this test. Which of the following is the most appropriate next step in the evaluation of this patient?

Adrenocorticotropic hormone (ACTH) stimulation test

0%

0/0

Follicle-stimulating hormone (FSH) level

0%

0/0

Luteinizing hormone (LH) level

0%

0/0

Karyotype

0%

0/0

Pituitary magnetic resonance imaging (MRI)

0%

0/0

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This 14-year-old patient who has not yet undergone menarche and has no secondary sexual characteristics (Tanner stage 1 breasts and pubic hair) requires evaluation for primary amenorrhea. Initial workup should include a thorough history and physical examination, pelvic ultrasound, serum beta-hCG levels, and follicle-stimulating hormone (FSH) levels.

Primary amenorrhea is defined by the absence of menarche by age 15 years in patients with secondary sexual characteristics, or by age 13 years in patients without secondary sexual characteristics. The initial evaluation of primary amenorrhea should include a thorough history and physical examination to determine if the uterus is present. Pelvic ultrasound can also be used to further evaluate the presence of the ovaries, uterus, and cervix, as well as other anatomic abnormalities of the reproductive tract. Initial laboratory testing should include serum beta-hCG levels, TSH, PRL, and FSH levels. Especially in patients without secondary sexual characteristics but with a uterus, FSH levels can help distinguish gonadal from central hypothalamic-pituitary disorders. The treatment of primary amenorrhea varies depending on the underlying etiology.

Yoon and Cheon reviewed the evaluation and management of amenorrhea associated with congenital sex hormonal disorders. The authors note that the management of primary amenorrhea varies considerably depending on etiology. The authors recommend that patients without secondary sexual characteristics and primary amenorrhea at age 13 should undergo measurement of FSH levels.

Incorrect Answers:
Answer 1: An adrenocorticotropic hormone (ACTH) stimulation test is useful in the evaluation of 17-alpha-hydroxylase deficiency, a potential etiology of primary amenorrhea. However, this test should only be performed in patients in which the FSH level is high and there are features of 17-alpha-hydroxylase deficiency (hypertension and minimal body hair).

Answer 3: Luteinizing hormone (LH) level is useful for evaluating the etiology of primary amenorrhea in patients without secondary sexual characteristics and a low FSH. A low LH suggests hypogonadotropic hypogonadism or hypothalamic-pituitary disorders.

Answer 4: Karyotyping should be performed in cases of primary amenorrhea in which there is a lack of secondary sexual characteristics and the FSH level is high. This can help distinguish between primary ovarian insufficiency (46,XX), gonadal dysgenesis (46,XY), and Turner syndrome (45,X).

Answer 5: Pituitary magnetic resonance imaging (MRI) can be used to evaluate sellar masses causing primary amenorrhea. Due to the high cost of this test, it should only be performed after laboratory testing for low FSH and LH in patients with primary amenorrhea.

Bullet Summary:
In patients with primary amenorrhea and a lack of secondary sexual characteristics, the next best step in management is assessing levels of follicle-stimulating hormone (FSH).

REFERENCES (1)
Authors
Rating
Please Rate Question Quality

0.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(0)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options